Hall MC - Search Results

1

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Hall MC, et al. Urology. 1998 Oct;52(4):594-601. doi: 10.1016/s0090-4295(98)00295-7. Urology. 1998. PMID: 9763077

2

Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy.

Hall MC, Womack JS, Roehrborn CG, Carmody T, Sagalowsky AI. Hall MC, et al. J Urol. 1998 Sep;160(3 Pt 1):703-6. doi: 10.1016/S0022-5347(01)62763-0. J Urol. 1998. PMID: 9720526

3

Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.

Hall MC, Fritzsch RJ, Sagalowsky AI, Ahrens A, Petty B, Roehrborn CG. Hall MC, et al. Urology. 1999 May;53(5):898-902; discussion 902-3. doi: 10.1016/s0090-4295(99)00061-8. Urology. 1999. PMID: 10223480 Clinical Trial.

4

The growth inhibitory effect of p21 adenovirus on human bladder cancer cells.

Hall MC, Li Y, Pong RC, Ely B, Sagalowsky AI, Hsieh JT. Hall MC, et al. J Urol. 2000 Mar;163(3):1033-8. J Urol. 2000. PMID: 10688044

5

Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?

Hall MC, Roehrborn CG, McConnell JD. Hall MC, et al. Semin Urol Oncol. 1996 Aug;14(3):122-33. Semin Urol Oncol. 1996. PMID: 8865473 Review.

6

Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.

Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, Wang Z, Hsieh JT. Li Y, et al. Among authors: hall mc. Cancer Res. 1999 Jan 15;59(2):325-30. Cancer Res. 1999. PMID: 9927041

7

Deoxyribonucleic acid flow cytometry and traditional pathologic variables in invasive penile carcinoma: assessment of prognostic significance.

Hall MC, Sanders JS, Vuitch F, Ramirez E, Pettaway CA. Hall MC, et al. Urology. 1998 Jul;52(1):111-6. doi: 10.1016/s0090-4295(98)00137-x. Urology. 1998. PMID: 9671880

8

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM. Clark PE, et al. Among authors: hall mc. Urology. 2004 Jun;63(6):1061-5. doi: 10.1016/j.urology.2004.01.035. Urology. 2004. PMID: 15183950 Clinical Trial.

9

Utility of frozen section analysis of resection margins during partial nephrectomy.

Kubinski DJ, Clark PE, Assimos DG, Hall MC. Kubinski DJ, et al. Among authors: hall mc. Urology. 2004 Jul;64(1):31-4. doi: 10.1016/j.urology.2004.03.011. Urology. 2004. PMID: 15245928 Review.

10

Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy.

Hall MC, Troncoso P, Pollack A, Zhau HY, Zagars GK, Chung LW, von Eschenbach AC. Hall MC, et al. Urology. 1994 Dec;44(6):869-75. doi: 10.1016/s0090-4295(94)80173-8. Urology. 1994. PMID: 7527168 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters